ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-1445 |   Health Care

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Aneurysmal Subarachnoid Hemorrhage Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET

7.1 GLOBAL ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA ANEURYSMAL SUBARACHNOID HEMORRHAGE MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Edge Therapeutics, Inc. (United States)

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Actelion Pharmaceuticals Ltd. (Switzerland)

16.3 Arbor Pharmaceuticals Inc. (United States)

16.4 Mayfield Brain & Spine (United States)

16.5 GE Healthcare (United States)

16.6 Koninklijke Philips N.V. (Netherland)

16.7 Siemens AG (Germany)

16.8 Trivitron Healthcare (India)

16.9 Toshiba Medical Systems Corporation (Japan)

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type
Computed Tomography (CT) Scan
Magnetic Resonance Imaging (MRI)
Lumbar Puncture
Xanthochromia
Cerebral Angiography
Transcranial Doppler Ultrasound
By Application
Hospitals
Clinics
Others
By Drug Class
Calcium Channel Blocker
Opioid Analgesic
Osmotic Agent
Anticonvulsant
Stool Softener
Others

Companies

Edge Therapeutics, Inc. (United States)
Actelion Pharmaceuticals Ltd. (Switzerland)
Arbor Pharmaceuticals Inc. (United States)
Mayfield Brain & Spine (United States)
GE Healthcare (United States)
Koninklijke Philips N.V. (Netherland)
Siemens AG (Germany)
Trivitron Healthcare (India)
Toshiba Medical Systems Corporation (Japan)

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.